Skip to Main Content

Paper Details

A Randomized, Double-blind, Phase II Trial of PSA-TRICOM (PROSTVAC) in Patients with Localized Prostate Cancer: The Immunotherapy to Prevent Progression on Active Surveillance Study.
Eur Urol Focus
14
2018
Localized Prostate Cancer, PSA, Patients, localized prostate cancer, patients
Author NameAffiliation
John K Parsonsuniversity of california san diego Moores Cancer Center
Christian P PavlovichJohns Hopkins Bayview Medical Center
  • 1 - 2

Datasets

Release 1.2